XOMA Royalty (XOMA) Current Deferred Revenue (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Current Deferred Revenue came in at $1.3 million in Q1 2026, down 5.77% year-on-year from $1.4 million in Q1 2025, and up 1.81% quarter-over-quarter from $1.3 million in Q4 2025.

XOMA Royalty (XOMA) Current Deferred Revenue (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Current Deferred Revenue across 17 years of filings, most recently posting $1.3 million for Q1 2026.

  • Current Deferred Revenue for Q1 2026 came in at $1.3 million, down 5.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 5.77% YoY), and the FY2025 annual result was $1.3 million, down 6.83% from the prior year.
  • Current Deferred Revenue came in at $1.3 million for Q1 2026 at XOMA Royalty, up from $1.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.3 million in Q2 2024 to a low of $1.3 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $1.7 million (2022), against an average of $1.7 million.
  • Across the five-year window, Current Deferred Revenue rose 21.95% in 2023 and sank 37.65% in 2025, its largest moves.
  • XOMA Royalty's Current Deferred Revenue stood at $1.9 million in 2022, then increased by 11.27% to $2.1 million in 2023, then tumbled by 35.59% to $1.4 million in 2024, then declined by 6.83% to $1.3 million in 2025, then grew by 1.81% to $1.3 million in 2026.
  • The last three Current Deferred Revenue figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.29 Mn
Dec 31, 2025 1.27 Mn
Sep 30, 2025 1.32 Mn
Jun 30, 2025 1.43 Mn
Mar 31, 2025 1.37 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 2.30 Mn
Mar 31, 2024 2.16 Mn
Dec 31, 2023 2.11 Mn
Sep 30, 2023 2.08 Mn
Jun 30, 2023 2.03 Mn
Mar 31, 2023 1.97 Mn
Dec 31, 2022 1.90 Mn
Sep 30, 2022 1.70 Mn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 1.62 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 1.54 Mn
Jun 30, 2021 1.50 Mn